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EXTRACELLULAR MATRIX METABOLISM
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Role of mitogen-activated protein kinases as downstream ef- either Smad2 or Smad3 is heteromerized with Smad4
fectors of transforming growth factor-b in mesangial cells. and then translocated into the nucleus, where these het-
Transforming growth factor-b (TGF-b) is a multifunctional eromers regulate transcription of TGF-b-target genescytokine that regulates cell proliferation, differentiation, and
such as collagen a1(I), plasminogen activator inhibitor-1production of extracellular matrix proteins in various types of
(PAI-1), Jun B, and c-Jun [8–12]. In addition, mitogen-cells including mesangial cells. Although TGF-b has been also
known as an important player in the pathogenesis of various activated protein kinases (MAPKs), such as extracellular
fibrotic diseases including glomerulosclerosis, signal-transduc- signal-regulated kinase (ERK), c-Jun N-terminal kinase
tion cascades of TGF-b have remained to be clarified. How- (JNK), and p38 MAP kinase [13–15] have also beenever, emerging evidence indicates that TGF-b can activate
found to participate in TGF-b signaling cascades. Inter-various signal transduction cascades such as Smad proteins and
estingly, a member of MAPKs activated by TGF-b hasmitogen-activated protein kinases (MAPKs) in many types of
cells. Here, we examine the role of MAPKs in TGF-b-induced been reported to be different among various types of
gene expression of extracellular matrix proteins in mesangial cells. ERK was shown to be activated by TGF-b in epi-
cells. TGF-b increases extracellular signal-regulated kinase
thelial cells [16], NIH 3T3 cells [17], breast cancer cells(ERK) activity, one of the MAPKs, and the expression of fibro-
[18], and mesangial cells [19]. JNK was activated innectin mRNA and protein in rat mesangial cells. Furthermore,
PD98059, a specific inhibitor of MAPK/ERK kinase (MEK), HepG2, MDCK, CHO [20], breast cancer cells [18], and
can inhibit this TGF-b-induced fibronectin expression. These mesangial cells [21], and p38 MAP kinase in epithelial
data suggest that MAPKs play an important role in TGF-b- cells [22], gingival fibroblasts [23], and neutrophils [24].
mediated extracellular matrix production in mesangial cells.
However, the precise role of MAPKs in TGF-b signaling
has been elucidated. Here, we show that ERK is involved
in TGF-b-induced fibronectin production in rat glomeru-Accumulation of extracellular matrix (ECM) proteins
lar mesangial cells.in the glomerular mesangial area is one of the main
pathologic findings in various glomerular diseases includ-
ing diabetic nephropathy [1, 2]. Glomerular mesangial METHODS
cells are believed to be responsible for overproduction Mesangial cells were obtained from a culture of glo-
of ECM proteins in various pathologic conditions [3, 4]. meruli, isolated from male Sprague-Dawley rats, in
Recently, transforming growth factor-b (TGF-b) has RPMI-1640 culture medium containing 20% fetal bovine
been proposed to play an important role in a process of serum and antibiotics [25]. Confluent mesangial cells
glomerular sclerosis, because of its ability to up-regulate were made quiescent by incubating in RPMI-1640 con-
gene expression of ECM proteins, such as collagen and
taining 0.2% bovine serum albumin for 24 h and stimu-
fibronectin, in mesangial cells [5, 6]. However, little is
lated with various concentrations of TGF-b1 for indi-known about signal transduction cascades responsible
cated time intervals. In some experiments, cells werefor TGF-b-induced ECM production in mesangial cells.
incubated with indicated concentrations of PD98059, aSmad proteins (Smads) have been delineated as signal
specific inhibitor of MAPK or ERK kinase (MEK), fortransducers of the TGF-b superfamily [7]. When TGF-b
90 min before exposure to TGF-b1. Northern blot analy-binds to its type II receptor, Smad2 and Smad3 are phos-
sis and inhibition enzyme-linked immunosorbent assayphorylated by type I receptor. After phosphorylation,
(ELISA) were performed to determine the expression
of fibronectin mRNA and protein, respectively, as pre-
Key words: Smad, fibronectin, extracellular matrix. viously described [26, 27]. Results were expressed as
mean 6 standard deviation (SD). Analysis of varianceÓ 2000 by the International Society of Nephrology
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Fig. 1. Effect of MEK inhibitor (PD98059)
on TGF-b1-induced fibronectin mRNA ex-
pression in mesangial cells. (A) Quiescent
mesangial cells were treated with various con-
centrations of PD98059 for 90 min and then
exposed to TGF-b1 for 6 h. The mRNA ex-
pression of fibronectin and 36B4 (an internal
standard) was measured by Northern blot
analysis. (B) Relative intensities of fibronectin
mRNA bands were quantitated by densito-
metric analysis. Data are presented as mean 6
standard deviation (SD) of three experiments.
*P , 0.01 vs. basal (without TGF-b1 treat-
ment), **P , 0.05 vs. TGF-b1 treatment with-
out PD98059. #P , 0.01 vs. TGF-b1 treatment
without PD98059.
(ANOVA) with subsequent Scheff’s test was used to
determine significant difference in multiple comparisons.
RESULTS AND DISCUSSION
Although it has been reported that TGF-b stimulates
MAPKs cascades in many types of cells, a member of
MAPKs activated by TGF-b is different among various
types of cells. In mesangial cells, we and others have
demonstrated that TGF-b can stimulate ERK and JNK
(abstract; Inoki et al, J Am Soc Nephrol 9:424A–425A,
1998) [21]. However, the role of these MAPKs in TGF-b-
induced production of ECM proteins has not been fully
understood. To clarify the role of ERK in TGF-b signal-
Fig. 2. Effect of MEK inhibitor (PD98059) on TGF-b1-induced pro-
ing, we examined the effect of a pharmacologic agent, duction of fibronectin. The concentrations of fibronectin in cultured
medium for 48 h were measured by inhibition enzyme-linked immuno-PD98059, which was shown to block ERK signaling selec-
sorbent assay. Quiescent mesangial cells were treated with 50 mmol/Ltively, on TGF-b-induced fibronectin expression in rat of PD98059 for 90 min before exposure to TGF-b1. Data are presented
glomerular mesangial cells. TGF-b1 stimulated expression as mean 6 SD (N 5 6). *P , 0.01 vs. basal (without TGF-b1 treatment).
of fibronectin mRNA in a dose-dependent (2.5 ng/ml max-
imum) and time-dependent manner, with a peak stimula-
tion at 6 h (data not shown). As shown in Fig. 1, PD98059 thesis requires activation of the ERK pathway in mesan-
could suppress an increase in the expression of fibronec- gial cells.
tin mRNA in a dose-dependent manner. PD98059 also Recently, Hocevar et al have reported that TGF-b
prevented TGF-b1-induced accumulation of fibronectin stimulates fibronectin synthesis in a JNK-dependent
protein in experimental culture medium (Fig. 2). These manner in human fibrosarcoma-derived cell line [28]. In
this report, TGF-b was shown to activate JNK, and theresults indicate that TGF-b1-stimulated fibronectin syn-
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Fig. 3. Interaction between the MAPKs
pathways and the Smad pathway in TGF-b
signaling. Coincident activation of MAPKs
and Smad pathways regulate the transcription
of specific genes cooperatively or separately
depend on the character of the promoter se-
quences of these genes.
stable expression of dominant negative forms of JNK1 protein-1 (AP-1), a heterodimer of c-Fos and c-Jun fam-
ily members. This hypothesis is supported by the follow-or MKK4, an upstream activator of JNK, was found
to result in a loss of TGF-b-stimulated expression of ing evidence. First, TGF-b was found to stimulate the ex-
pression of several genes including collagen a1 (I), PAI-1fibronectin mRNA and protein. Interestingly, in this cell
line, TGF-b-mediated fibronectin production did not re- and TGF-b itself through the activation of AP-1 DNA
binding [32]. Second, it has been reported that AP-1quire the activation of either ERK or p38 MAP kinase.
They also demonstrated that TGF-b was able to stimu- complexes can activate CRE sequence [33, 34]. Further
study is necessary to elucidate the precise role of MAPKslate fibronectin expression in MDM-MB 468, BxPC3,
and SW480.7 cell line, which did not express endogenous in TGF-b-induced gene expression of fibronectin.
Insight into the mechanism of TGF-b-regulated geneSmad4 protein, thus suggesting that TGF-b could stimu-
late fibronectin expression in a Smad-independent man- expression indicates that the Smad pathway is important
in the regulation of the expression of various genes. Thus,ner. Taken together, although TGF-b stimulates differ-
ent members of MAPKs in several types of cells, ERK Smads are now thought to be main transducers of TGF-b
signaling. Conversely, several investigators have recentlyand JNK pathways are thought to play an important role
in TGF-b-induced fibronectin production. However, the suggested that MAPKs cascades stimulated by TGF-b
are also involved in the regulation of TGF-b-inducedprecise mechanism by which MAPKs mediate TGF-b-
induced fibronectin production remains unknown. genetic expression including collagen a1 (I), p21WAF1/CIP1,
and PAI-1 in various types of cells [17, 21, 35]. Interest-TGF-b has been reported to regulate both transcrip-
tional activity of fibronectin gene and mRNA stability ingly, some of these genes are also regulated by the
Smad pathway, indicating that both MAPKs and Smads[29]. Indeed, Dean et al indicated that TGF-b was able
to stimulate a construct containing a human fibronectin contribute to TGF-b-induced gene expression and that
cross talk between them might exist. A possible modelpromoter in reporter analysis [30]. This construct con-
tained a cyclic adenosine monophosphate responsive ele- of cross talk between MAPKs cascades and Smad path-
way is depicted in Fig. 3. The MAPKs cascades and thement (CRE) (, minus . 170) sequence that was shown
to respond to serum [30] or cyclic adenosine monophos- Smad pathway activated by TGF-b are related at several
points. Recent studies have revealed that ERK and JNKphate (cAMP) [31]. Thus, CRE could possibly be acti-
vated by MAPKs through the formation of activated are able to phosphorylate Smads and regulate nuclear
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cades activated by tress and inflammation. J Biol Chem 271:24313–translocation and DNA binding of Smads. It has been
24316, 1996
also reported that c-Fos and Jun family, which are regu- 15. Woodgett JR, Avruch J, Kyriakis J: The stress activated protein
kinase pathway. Cancer Surv 27:127–138, 1996lated by ERK and JNK, can bind to Smad3 directly [9,
16. Hartsough MT, Mulder KM: Transforming growth factor-b acti-32, 36, 37] and that Smad3-Smad4 heterodimer can bind
vation of p44 mapk in proliferating cultures of epithelial cells.
AP-1 binding site [9]. Hence, TGF-b modulates various J Biol Chem 270:7117–7124, 1995
17. Mucsi I, Skorecki KL, Goldberg HJ: Extracellular signal-regu-transcriptional complexes by the activation of MAPKs
lated kinase and the small GTP-binding protein, Rac, contributecascades or the Smad pathway and regulates different
to the effects of transforming growth factor-b1 on gene expression.
genes in different cells depending on the promoter se- J Biol Chem 271:16567–16572, 1996
18. Frey RS, Mulder KM: Involvement of extracellular signal-regu-quences of TGF-b-target genes. However, cross talk be-
lated kinase 2 and stress-activated protein kinase/Jun N-terminaltween the MAPKs cascades and the Smad pathway de-
kinase activation by transforming growth factor-b in the negative
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